Breast Surgery Practice Questions

Q: What type of radiation is used in mammography?

Bremsstrahlung X-ray. ### Explanation **Correct Option: B. Bremsstrahlung X-ray** Mammography utilizes low-energy X-rays to achieve high-contrast images of soft breast tissue. These X-rays are primarily produced via **Bremsstrahlung (braking) radiation**. This occurs when high-speed electrons from the cathode are decelerated by the electric field of the target nucleus (usually Molybdenum or Rhodium), releasing energy in the form of photons. In mammography, the goal is to produce a "monochromatic" or narrow-spectrum beam (typically 15–30 keV) to differentiate between water, fat, and calcium densities. **Analysis of Incorrect Options:** * **A. Conventional X-ray:** While mammography is a form of X-ray, "conventional" usually refers to high-voltage (kVp) imaging used for bones/chest. Mammography requires **low kVp** and specific target/filter combinations (Mo/Mo or Mo/Rh) to enhance soft tissue contrast, which distinguishes it from general radiography. * **C. Low amperage X-ray:** Amperage (mA) controls the *quantity* (intensity) of X-rays, not the type of radiation. While mammography uses specific settings, "low amperage" is not the defining physical principle of the radiation produced. * **D. Stereo Ray:** This is a distractor term. Stereotactic imaging is a *technique* used for breast biopsies, but it is not a type of radiation. **High-Yield Clinical Pearls for NEET-PG:** * **Target Materials:** Molybdenum (Mo) is the most common target; Rhodium (Rh) is used for denser/thicker breasts. * **Window:** Mammography tubes use a **Beryllium window** instead of glass to prevent the absorption of low-energy X-rays. * **Best Time for Mammography:** Day 7 to 10 of the menstrual cycle (when breast tenderness and engorgement are minimal). * **Screening:** The standard views are **Craniocaudal (CC)** and **Mediolateral Oblique (MLO)**. The MLO view is best for visualizing the Upper Outer Quadrant and the Axillary Tail of Spence.

Q: Peau d'orange develops due to which of the following?

Lymphatic obstruction. **Explanation:** **Peau d'orange** (French for "orange peel skin") is a classic clinical sign of inflammatory breast cancer or advanced malignancy. **Why Lymphatic Obstruction is Correct:** The characteristic appearance occurs due to **cutaneous lymphatic obstruction** by tumor emboli. When the deep lymphatics are blocked, it leads to localized lymphedema of the skin. The skin becomes thickened and edematous; however, the hair follicles and sweat glands remain tethered to the underlying subcutaneous fenestrations (Cooper’s ligaments). This creates a pitted, dimpled appearance resembling the skin of an orange. **Analysis of Incorrect Options:** * **Vascular obstruction:** While venous congestion can cause edema, it does not produce the specific "pitted" tethering seen in peau d'orange. * **Local spread:** While the tumor is spreading locally, the specific skin change is a secondary mechanical effect of lymphatic blockage, not the direct invasion of the skin surface itself. * **Endocrinal abnormality:** Hormonal changes (like estrogen excess) can cause breast tenderness or gynecomastia but do not lead to structural skin changes like peau d'orange. **High-Yield Clinical Pearls for NEET-PG:** * **TNM Staging:** The presence of peau d'orange automatically categorizes a breast cancer as **T4b**. * **Differential Diagnosis:** While most commonly associated with breast carcinoma, it can also be seen in severe mastitis or cellulitis. * **Cooper’s Ligaments:** Remember that **skin dimpling** is due to the involvement of Cooper’s ligaments, whereas **peau d'orange** is specifically due to lymphatic edema. * **Biopsy:** If inflammatory breast cancer is suspected, a punch biopsy of the skin may show tumor emboli within the dermal lymphatics.

Q: Which of the following genetic predispositions is associated with the least risk of breast cancer?

Ataxia telangiectasia. ### Explanation The risk of developing breast cancer is categorized based on the **penetrance** of the associated genetic mutation. **1. Why Ataxia Telangiectasia is the correct answer:** Ataxia telangiectasia is caused by a mutation in the **ATM gene**. It is considered a **moderate-penetrance** gene. While it does increase the risk of breast cancer compared to the general population, the lifetime risk is approximately **20–30%**. This is significantly lower than the risks associated with high-penetrance syndromes like BRCA or Li-Fraumeni. **2. Why the other options are incorrect:** * **BRCA1 & BRCA2 Mutations:** These are the most common **high-penetrance** mutations. BRCA1 carries a lifetime breast cancer risk of **60–80%**, while BRCA2 carries a risk of **45–70%**. BRCA1 is also strongly associated with triple-negative breast cancer. * **Li-Fraumeni Syndrome:** Caused by a germline mutation in the **TP53** tumor suppressor gene. It is a highly penetrant syndrome where the lifetime risk of breast cancer in females is nearly **90%**, often occurring at a very young age (pre-menopausal). **3. NEET-PG High-Yield Pearls:** * **High-Penetrance Genes (Risk >50%):** BRCA1, BRCA2, TP53 (Li-Fraumeni), PTEN (Cowden Syndrome), STK11 (Peutz-Jeghers). * **Moderate-Penetrance Genes (Risk 20-40%):** ATM, CHEK2, PALB2, BRIP1. * **Male Breast Cancer:** Most strongly associated with **BRCA2** (approx. 7% lifetime risk). * **Screening:** Patients with high-risk genetic mutations should begin screening earlier (often at age 25 or 10 years before the youngest affected relative) using **Annual Contrast-Enhanced MRI** in addition to mammography.

Q: Which of the following are NOT associated with breast cancer?

Fibroadenoma, Moderate hyperplasia. To answer this question, we must categorize benign breast diseases based on their risk of progressing to malignancy, as defined by the **Dupont and Page classification**. ### **1. Why Option B is Correct** The question asks for conditions **NOT** associated with an increased risk of breast cancer. * **Fibroadenoma:** This is a benign fibroepithelial tumor. Simple fibroadenomas carry **no increased risk** (Relative Risk ≈ 1.0) of developing breast cancer. * **Moderate Hyperplasia (without atypia):** While "mild" hyperplasia has no risk, "moderate or florid" hyperplasia without atypia carries only a **slightly increased risk** (RR 1.5–2.0). In the context of NEET-PG, when compared to high-risk lesions like BRCA mutations or atypical hyperplasia, these are considered the "least associated" or clinically insignificant regarding cancer progression. ### **2. Analysis of Incorrect Options** * **Option A & D:** These include **BRCA 1 & BRCA 2** mutations, which are the strongest genetic risk factors for breast cancer (Lifetime risk up to 70-80%). **Apocrine metaplasia** (found in Option A) is a common component of fibrocystic change and carries no risk, but the presence of BRCA makes these options incorrect. * **Option C:** Includes **Atypical Ductal Hyperplasia (ADH)**. ADH is a high-risk precursor lesion with a Relative Risk of **4.0–5.0**. ### **3. NEET-PG High-Yield Pearls** * **No Increased Risk (RR 1.0):** Adenosis, duct ectasia, simple cysts, apocrine metaplasia, mild hyperplasia, and simple fibroadenoma. * **Slightly Increased Risk (RR 1.5–2.0):** Moderate/florid hyperplasia (without atypia), sclerosing adenosis, and complex sclerosing lesion (radial scar), papillomas. * **Moderately Increased Risk (RR 4.0–5.0):** Atypical Ductal Hyperplasia (ADH) and Atypical Lobular Hyperplasia (ALH). * **Highest Risk:** BRCA mutations, LCIS (Lobular Carcinoma in Situ), and DCIS (Ductal Carcinoma in Situ).

Q: Which quadrant of the breast is the least common site for cancer?

Lower Inner Quadrant. **Explanation:** The distribution of breast cancer is directly proportional to the volume of glandular (ductal and lobular) tissue present in each quadrant. The **Lower Inner Quadrant (LIQ)** contains the least amount of breast parenchyma compared to other regions, making it the least common site for primary breast malignancies (approximately 2–5%). **Analysis of Options:** * **Lower Inner Quadrant (Correct):** As mentioned, this area has the lowest density of terminal duct lobular units (TDLUs), the site where most cancers originate. * **Superior Outer Quadrant (Incorrect):** This is the **most common site** (approx. 50%) because it contains the largest volume of glandular tissue and extends into the axillary tail of Spence. * **Inferior Outer Quadrant (Incorrect):** This accounts for roughly 10% of cases, making it more common than the inner quadrants but less common than the upper outer quadrant. * **Subareolar/Central (Incorrect):** This region accounts for about 15–20% of cancers. Tumors here often present with nipple retraction or discharge. **High-Yield Clinical Pearls for NEET-PG:** 1. **Frequency Ranking:** Upper Outer (50%) > Central/Subareolar (15-20%) > Upper Inner (15%) > Lower Outer (10%) > **Lower Inner (2-5%)**. 2. **Prognosis:** Tumors in the **inner quadrants** (UIQ and LIQ) have a slightly higher risk of involving the **internal mammary lymph nodes**, which can sometimes lead to a worse prognosis due to "silent" metastasis compared to the more accessible axillary nodes. 3. **Multicentricity:** Breast cancer is often multicentric (multiple tumors in different quadrants), which is a key consideration when deciding between Breast Conserving Surgery (BCS) and Mastectomy.

Q: The Gail Model is used for risk assessment of which of the following?

Breast cancer. **Explanation:** The **Gail Model** (also known as the Breast Cancer Risk Assessment Tool) is a widely used clinical tool designed to estimate a woman's risk of developing **invasive breast cancer** over the next five years and over her lifetime (up to age 90). It utilizes specific personal and family history factors to calculate risk. **Why Breast Cancer is Correct:** The model incorporates key risk factors including: * Current age. * Age at menarche. * Age at first live birth. * Number of previous breast biopsies and presence of atypical hyperplasia. * Number of first-degree relatives with breast cancer. * Race/ethnicity. **Why Other Options are Incorrect:** * **Ovarian Cancer:** Risk is typically assessed using the **ROMA score** (Risk of Ovarian Malignancy Algorithm) or genetic testing for BRCA1/2 mutations. * **Prostate Cancer:** Screening and risk are primarily assessed via **PSA levels** and the **IPSS score** (for symptoms), not the Gail Model. * **Lung Cancer:** Risk is determined by smoking history (pack-years) and assessed using low-dose CT screening criteria (e.g., USPSTF guidelines). **High-Yield Clinical Pearls for NEET-PG:** * **Threshold for Intervention:** A 5-year risk score of **≥1.67%** is considered "high risk." In such patients, chemoprevention with Selective Estrogen Receptor Modulators (SERMs) like **Tamoxifen** or **Raloxifene** may be indicated. * **Limitations:** The Gail Model **underestimates** risk in women with a strong family history of paternal breast cancer or those with known **BRCA1/2 mutations**. For these patients, the **Claus Model** or **BRCAPRO** is preferred. * **Modified Gail Model:** This version is specifically validated for use in various ethnic groups, including Asian Americans.

Q: A 35-year-old premenopausal patient has recently developed a 1.5 cm sized pigmented lesion on her back. Which of the following forms of tissue diagnosis will you recommend for her?

Excision biopsy. **Explanation:** The clinical presentation of a new, pigmented lesion in a 35-year-old patient must be managed with a high index of suspicion for **Malignant Melanoma**. **1. Why Excision Biopsy is the Correct Choice:** For any suspicious pigmented lesion, the gold standard for diagnosis is an **Excisional Biopsy** with a narrow margin (typically 1–3 mm). The primary reason is that the prognosis and surgical management of melanoma are determined by the **Breslow Depth** (the vertical thickness of the tumor in millimeters). An excisional biopsy provides the pathologist with the entire architecture of the lesion, allowing for an accurate measurement of depth and ensuring no "sampling error" occurs. **2. Why Other Options are Incorrect:** * **Needle Biopsy (FNAC) & Trucut Biopsy (Options A & B):** These provide only cytological or small architectural samples. They are insufficient for determining the Breslow depth and have a high rate of false negatives in pigmented lesions. * **Incisional Biopsy (Option D):** This involves taking only a piece of the lesion. It is generally contraindicated for small pigmented lesions because it may miss the thickest part of the tumor (leading to understaging) and theoretically risks "seeding" or disrupting the local lymphatics, though the latter is debated. It is only reserved for very large lesions or those in cosmetically sensitive areas (e.g., face, subungual). **Clinical Pearls for NEET-PG:** * **Breslow Thickness:** The most important prognostic factor in cutaneous melanoma. * **ABCDE Criteria:** Used to identify suspicious lesions (Asymmetry, Border irregularity, Color variegation, Diameter >6mm, Evolving). * **Safety Margins:** Once melanoma is confirmed via excision biopsy, a **Wide Local Excision (WLE)** is performed with margins based on the Breslow depth (e.g., 1 cm margin for depth 2 mm).

Question 1

What type of radiation is used in mammography?

Accepted Answer

Bremsstrahlung X-ray

Answer

Conventional X-ray

Answer

Low amperage X-ray

Answer

Stereo Ray

Question 2

Peau d'orange develops due to which of the following?

Accepted Answer

Lymphatic obstruction

Answer

Vascular obstruction

Answer

Local spread

Answer

Endocrinal abnormality

Question 3

Which of the following genetic predispositions is associated with the least risk of breast cancer?

Accepted Answer

Ataxia telangiectasia

Answer

BRCA1 mutation

Answer

BRCA2 mutation

Answer

Li-Fraumeni syndrome

Question 4

Which of the following are NOT associated with breast cancer?

Accepted Answer

Fibroadenoma, Moderate hyperplasia

Answer

BRCA 1 & BRCA 2, Apocrine metaplasia, Moderate hyperplasia

Answer

Atypical ductal hyperplasia, Moderate hyperplasia, Fibroadenoma

Answer

BRCA 1 & BRCA 2, Atypical ductal hyperplasia, Moderate hyperplasia

Question 5

In which one of the following types of carcinoma of the breast is a biopsy of the opposite breast advised?

Accepted Answer

Lobular carcinoma

Answer

Inflammatory carcinoma

Answer

Medullary carcinoma

Answer

Scirrhous carcinoma

Question 6

Which quadrant of the breast is the least common site for cancer?

Accepted Answer

Lower Inner Quadrant

Answer

Superior Outer

Answer

Inferior Outer

Answer

Subareolar

Question 7

A 26-year-old breastfeeding woman presents with redness, pain around the nipple, and purulent discharge. Staphylococcus aureus was cultured from the discharge. Which of the following statements is true about the patient's condition?

Accepted Answer

This condition mostly occurs during the first month of breastfeeding.

Answer

NSAIDs are contraindicated in this condition.

Answer

The patient is suffering from periductal mastitis.

Answer

Breastfeeding is contraindicated.

Question 8

The Gail Model is used for risk assessment of which of the following?

Accepted Answer

Breast cancer

Answer

Ovarian cancer

Answer

Prostate cancer

Answer

Lung cancer

Question 9

A 42-year-old woman presents with a swollen, painful, erythematous left breast which does not respond to a 10-day course of oxacillin. Ultrasound reveals no abscess. What is the next step in management?

Accepted Answer

Biopsy the skin and parenchyma of the breast

Answer

Begin a 10-day course of vancomycin

Answer

Workup the patient for an immunosuppressive disease

Answer

Incision and drainage of the area

Question 10

A 35-year-old premenopausal patient has recently developed a 1.5 cm sized pigmented lesion on her back. Which of the following forms of tissue diagnosis will you recommend for her?

Accepted Answer

Excision biopsy

Answer

Needle biopsy

Answer

Trucut biopsy

Answer

Incisional biopsy

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?